Vistide (cidofovir recalls

The FDA has published 1 recall involving Vistide (cidofovir since 2013. The latest was reported on 22 May 2013. Most were for particulate matter. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2013

Last 12 months0reported

Class I1100% of total

Ongoing0latest 22 May 2013

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 1 100%Class II 0 0%Class III 0 0%

Why vistide (cidofovir is recalled

Particulate Matter1100%

Companies

Gilead Sciences1100%

By year

20131100%

All vistide (cidofovir recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
22 May 2013Drug	CLASS I	Vistide (cidofovir) Injection, 375 mg (75 mg/mL) single-use vial recalled	Gilead Sciences	Particulate Matter	Nationwide

Should you stop taking Vistide (cidofovir?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.